Citigroup’s Direxion Daily Healthcare Bull 3X ETF CURE Stock Holding History
Bought
Maintained
Sold
Other funds holding CURE
HF
TRCT
TCM
VF
CIA
QT
KFS
Citigroup's CURE Position: Q3 2022 in Review
Citigroup sold out of Direxion Daily Healthcare Bull 3X ETF (CURE) in Q3 2022, closing a stake of 300 shares — an estimated $31K sold.
Citigroup first reported a position in CURE in Q1 2016 and held it in 6 quarters. The position peaked at $43K in Q4 2021. 18 funds tracked by Wall St. Rank hold CURE as of Q3 2022.
- Citigroup reported no remaining Direxion Daily Healthcare Bull 3X ETF position as of Q3 2022 after selling out during the quarter.
- Citigroup sold 300 Direxion Daily Healthcare Bull 3X ETF shares in Q3 2022, an estimated $31K.
- Citigroup first reported a position in Direxion Daily Healthcare Bull 3X ETF in Q1 2016 and held it in 6 quarters.
- Citigroup's Direxion Daily Healthcare Bull 3X ETF position peaked at $43K in Q4 2021.
- 18 funds tracked by Wall St. Rank held Direxion Daily Healthcare Bull 3X ETF as of Q3 2022.
Based on Citigroup's 13F filing for Q3 2022, filed 10 Nov 2022.